Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.73 |
| ▸ | DPP8 | Q6V1X1 | 12/20 | 0.73 |
| ▸ | DPP7 | Q9UHL4 | 10/20 | 0.73 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.64 |
| ▸ | FAP | Q12884 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3847095 | 0.85 | DPP4 (0.78) | DPP4DPP8DPP7DPP9FAP | |
| Hydrochloric Acid SCHEMBL2710259 | 0.85 | DPP4 (0.77) | DPP4DPP8DPP7DPP9 | |
| SCHEMBL3841337 | 0.85 | DPP4 (1.00) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3844868 | 0.83 | DPP4 (0.75) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3849234 | 0.83 | DPP4 (0.79) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3842842 | 0.82 | DPP4 (0.93) | DPP4DPP8DPP7DPP9FAP | |
| Hydrochloric Acid SCHEMBL2709769 | 0.81 | DPP4 (0.98) | DPP4DPP8DPP9 | |
| SCHEMBL3846398 | 0.80 | DPP4 (1.00) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3842814 | 0.79 | DPP4 (0.72) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3861833 | 0.79 | DPP4 (0.69) | DPP4DPP8DPP7DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10792853-B2 | Method and device for producing a 3-D substrate coated with a laminate | LEONHARD KURZ STIFTUNG & CO. KG (DE) | 2020-10-06 | — | — | US | claimed |
| US-20200276747-A9 | METHOD AND DEVICE FOR PRODUCING A 3-D SUBSTRATE COATED WITH A LAMINATE | LEONHARD KURZ STIFTUNG & CO. KG (DE) | 2020-09-03 | — | — | US | claimed |
| US-20180207853-A1 | METHOD AND DEVICE FOR PRODUCING A 3-D SUBSTRATE COATED WITH A LAMINATE | NIEBLING CURT (DE) | 2018-07-26 | — | — | US | claimed |
| EP-2131830-B1 | PHARMACEUTICAL FORM WITH IMPEDED ABUSE | GRUENENTHAL GMBH (DE) | 2017-05-10 | — | — | EP | claimed |
| EP-2131830-A2 | PHARMACEUTICAL FORM WITH IMPEDED ABUSE | Grünenthal GmbH (DE) | 2009-12-16 | — | — | EP | claimed |
| WO-2008107149-A2 | PHARMACEUTICAL FORM WITH IMPEDED ABUSE | Grünenthal GmbH (DE) | 2008-09-12 | — | — | WO | claimed |
| US-11351718-B2 | Overmoulding by 3D printing | PLASTIC OMNIUM ADVANCED INNOVATION AND RESEARCH (BE) | 2022-06-07 | — | — | US | disclosed |
| US-20190283314-A1 | OVERMOULDING BY 3D PRINTING | PLASTIC OMNIUM ADVANCED INNOVATION AND RESEARCH (BE) | 2019-09-19 | — | — | US | disclosed |
| EP-2131830-B1 | PHARMACEUTICAL FORM WITH IMPEDED ABUSE | GRUENENTHAL GMBH (DE) | 2017-05-10 | — | — | EP | disclosed |
| EP-2116541-B1 | Proline derivatives and their use as dipeptidyl peptidase IV inhibitors | PFIZER PROD INC (US) | 2015-02-25 | — | — | EP | disclosed |
| EP-1786403-B1 | ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE CONTAINING (1R, 2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | GRUENENTHAL GMBH (DE) | 2013-07-24 | — | — | EP | disclosed |
| EP-1765303-B1 | ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE | GRUENENTHAL GMBH (DE) | 2013-02-20 | — | — | EP | disclosed |
| EP-1765298-B1 | METHOD FOR PRODUCING A SOLID DOSAGE FORM, WHICH IS SAFEGUARDED AGAINST ABUSE, WHILE USING A PLANETARY GEAR EXTRUDER | GRUENENTHAL GMBH (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-1699440-A1 | METHOD FOR THE PRODUCTION OF AN ADMINISTRATION FORM WHICH IS SECURED AGAINST MISUSE | Grünenthal GmbH (DE) | 2006-09-13 | — | — | EP | disclosed |
| WO-2006002883-A1 | METHOD FOR PRODUCING A SOLID DOSAGE FORM, WHICH IS SAFEGUARDED AGAINST ABUSE, WHILE USING A PLANETARY GEAR EXTRUDER | Grünenthal GmbH (DE) | 2006-01-12 | — | — | WO | disclosed |
| WO-2006002886-A1 | ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE CONTAINING (1R, 2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | Grünenthal GmbH (DE) | 2006-01-12 | — | — | WO | disclosed |
| WO-2006002884-A1 | ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE | Grünenthal GmbH (DE) | 2006-01-12 | — | — | WO | disclosed |
| WO-2005063214-A1 | METHOD FOR THE PRODUCTION OF AN ADMINISTRATION FORM WHICH IS SECURED AGAINST MISUSE | Grünenthal GmbH (DE) | 2005-07-14 | — | — | WO | disclosed |
| EP-0639631-B1 | Process for preparing syngas | CELANESE GMBH (DE) | 1999-11-24 | — | — | EP | disclosed |
| EP-0639631-A1 | Process for preparing syngas | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-02-22 | — | — | EP | disclosed |